Results 131 to 140 of about 7,521 (213)

HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection. [PDF]

JHEP Rep, 2019
Ferrando-Martinez S, Huang K, Bennett AS, Sterba P, Yu L, Suzich JA, Janssen HLA, Robbins SH.   +7 more
europepmc   +1 more source

Predictive value of serum HBV RNA on HBeAg seroconversion in treated chronic hepatitis B patients. [PDF]

Eur J Gastroenterol Hepatol
Liu T, Shi Y, Wu J, Qin L, Qi Y.
europepmc   +1 more source

CTLA-4 haplotype predicts HBsAg and HBcrAg levels and HBeAg seroconversion age in children with chronic HBV infection. [PDF]

JHEP Rep
Wu JF, Tai CS, Chang KC, Chen TW, Chen HL, Ni YH, Hsu HY, Chang MH.   +7 more
europepmc   +1 more source

Increasing plasma ADAMTS13 activity is associated with HBeAg seroconversion in chronic hepatitis B patients during 5 years of entecavir treatment. [PDF]

Sci Rep, 2019
Guo R, Xie Y, Yang J, Lu H, Ye P, Jin L, Lin W.   +6 more
europepmc   +1 more source

Natural history of chronic hepatitis B virus infection from infancy to adult life -the mechanism of inflammation triggering and long-term impacts [PDF]

, 2015

core   +1 more source

Serum hepatitis B virus RNA is a predictor of HBeAg seroconversion and virological response with entecavir treatment in chronic hepatitis B patients. [PDF]

World J Gastroenterol, 2019
Luo H, Zhang XX, Cao LH, Tan N, Kang Q, Xi HL, Yu M, Xu XY.   +7 more
europepmc   +1 more source

Elevated pre-treatment IL-18 level is associated with HBeAg seroconversion in HIV-HBV coinfection. [PDF]

Antivir Ther, 2017
Li Y, Xie J, Wang H, Han Y, Wang N, Thio CL, Li T.   +6 more
europepmc   +1 more source

Efficacy of NAs in combination with Peg-IFN for functional cure in patients with CHB: a meta-analysis of RCTs. [PDF]

Ann Med
Zhang Y, Zhang Z, Li X, Cao W, Wang S, Deng W, Wei X, Yao L, Xie Y, Li M.   +9 more
europepmc   +1 more source

Combination Therapy for Chronic Hepatitis B: Current Indications [PDF]

, 2011
Navin Paul, Steven-Huy Han
core   +1 more source

A meta-analysis of controlled clinical trials comparing peginterferon-α plus nucleos(t)ide analogs versus peginterferon-α monotherapy for HBsAg clearance or seroconversion in patients with chronic hepatitis B. [PDF]

Front Med (Lausanne)
Zhu S, Yang Z, Wang Y, Cai X, Qin C.
europepmc   +1 more source